AstraZeneca Sells Anesthetics Rights to Aspen

15.09.2017 - AstraZeneca has agreed to sell the remaining rights to its anesthetic drugs portfolio to Aspen Global Incorporated (AGI) in a deal worth up to $766 million. The portfolio comprises...